| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,010 |
965 |
$106K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,438 |
1,360 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,095 |
1,064 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
509 |
500 |
$37K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
776 |
776 |
$31K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,242 |
1,239 |
$13K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
152 |
152 |
$13K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,248 |
1,248 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
449 |
439 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
79 |
79 |
$7K |
| 87634 |
|
215 |
209 |
$6K |
| 90461 |
|
123 |
123 |
$5K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
27 |
27 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
24 |
24 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
104 |
103 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
47 |
46 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
20 |
19 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
49 |
49 |
$598.29 |
| 94760 |
|
271 |
262 |
$534.60 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
37 |
35 |
$452.51 |